(ETSX) Evolve S&P/TSX 60 Enhanced - Ratings and Ratios
S&P/TSX 60 ETF, Enhanced Yield Strategy
Description: ETSX Evolve S&P/TSX 60 Enhanced
The Evolve S&P/TSX60 Enhanced Yield Fund CAD Unhedged (ETSX) is an exchange-traded fund (ETF) that focuses on generating enhanced yields for investors by investing in the S&P/TSX 60 Index, which comprises the 60 largest and most liquid stocks listed on the Toronto Stock Exchange. This fund is designed for investors seeking exposure to the Canadian equity market with a strategy aimed at maximizing income through various yield-enhancing strategies.
Given its investment objective, ETSX is likely employing a strategy that may include dividend capture, options overlay, or other yield-enhancing techniques to achieve its goal of enhanced yield. The funds AUM of $44.68M CAD indicates a relatively modest size, which could be a result of its specific strategy or market conditions. Despite its size, the funds focus on large-cap Canadian equities provides a certain level of stability and liquidity.
Analyzing the technical data, the ETFs price is currently at $21.29, slightly below its 52-week high of $21.31. The short-term moving averages (SMA20 at $20.68 and SMA50 at $20.28) suggest a positive trend, as the current price is above both. The long-term SMA200 at $20.03 further reinforces the notion of an overall uptrend. The Average True Range (ATR) of $0.24, representing 1.13% of the current price, indicates relatively moderate volatility.
Combining technical and fundamental analysis, a forecast for ETSX could involve assessing whether the current price is likely to continue its upward trend or if the yield-enhancing strategy will be impacted by market conditions. If the S&P/TSX 60 Index continues to perform well and the yield-enhancing strategies employed by the fund remain effective, ETSX could potentially maintain its current levels or move closer to its 52-week high. However, a decline in the underlying index or increased market volatility could negatively impact the funds performance.
Based on the available data, a potential forecast could be that ETSX may continue to trade within a narrow range, potentially testing its 52-week high if the Canadian equity market remains stable and the yield-enhancing strategies continue to be effective. Investors should monitor the funds AUM, the performance of the S&P/TSX 60 Index, and overall market conditions to adjust their expectations accordingly.
ETSX ETF Overview
Market Cap in USD | 49m |
Category | Canadian Equity |
IPO / Inception | 2023-01-09 |
ETSX ETF Ratings
Growth Rating | 65.4 |
Fundamental | - |
Dividend Rating | 72.9 |
Rel. Strength | 1.37 |
Analysts | - |
Fair Price Momentum | 23.53 CAD |
Fair Price DCF | - |
ETSX Dividends
Dividend Yield 12m | 9.95% |
Yield on Cost 5y | 13.38% |
Annual Growth 5y | 0.00% |
Payout Consistency | 98.3% |
Payout Ratio | % |
ETSX Growth Ratios
Growth Correlation 3m | 97% |
Growth Correlation 12m | 82.3% |
Growth Correlation 5y | 93.2% |
CAGR 5y | 14.18% |
CAGR/Max DD 5y | 1.16 |
Sharpe Ratio 12m | 1.50 |
Alpha | 9.39 |
Beta | 0.572 |
Volatility | 9.83% |
Current Volume | 0.5k |
Average Volume 20d | 1.3k |
Stop Loss | 21.3 (-3.2%) |
What is the price of ETSX shares?
As of August 13, 2025, the stock is trading at CAD 22.00 with a total of 500 shares traded.Over the past week, the price has changed by +1.24%, over one month by +2.17%, over three months by +7.85% and over the past year by +23.79%.
Is Evolve S&P/TSX 60 Enhanced a good stock to buy?
Yes. Based on ValueRay's Analyses, Evolve S&P/TSX 60 Enhanced (TO:ETSX) is currently (August 2025) a good stock to buy. It has a ValueRay Growth Rating of 65.42 and therefor a clear technical positive rating according to historical growth.Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ETSX is around 23.53 CAD . This means that ETSX is currently overvalued and has a potential downside of 6.95%.
Is ETSX a buy, sell or hold?
Evolve S&P/TSX 60 Enhanced has no consensus analysts rating.What are the forecasts/targets for the ETSX price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 26.2 | 18.9% |
ETSX Fundamental Data Overview
Market Cap CAD = 67.9m (67.9m CAD * 1.0 CAD.CAD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 CAD
Beta = 0.0
Revenue TTM = 0.0 CAD
EBIT TTM = 0.0 CAD
EBITDA TTM = 0.0 CAD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 67.9m CAD (67.9m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 67.9m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 67.9m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(67.9m)/V(0.0) * Re(8.12%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
Discount Rate = 8.12% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)